QURE Stock: Price, Earnings History and SEC Filings
uniQure N.V. (QURE) last traded at $24.83, down 1.86% on the latest session and up 2.8% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-1.22 against an analyst estimate of $-0.81, a miss of 50.6%.
$24.83 -1.86%
1 month+2.77%
52-week high$51.72
52-week low$8.73
Volume1.90M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
QURE earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Jul 29, 2026 | $-1.22 | $-0.81 | -50.62% |
| Mar 2026 | May 5, 2026 | $-0.85 | $-0.88 | +3.41% |
| Dec 2025 | Mar 2, 2026 | $-0.56 | $-0.93 | +39.78% |
| Sep 2025 | Nov 10, 2025 | $-1.38 | $-0.85 | -62.35% |
QURE beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for QURE
SEC filing data is not available right now. You can search for QURE on SEC EDGAR.
QURE news
- 3 Promising Genomics Stocks to Add to Your Portfolio NowOct 30, 2026 · finance.yahoo.com
- uniQure (QURE) Stock Could Be Overvalued Despite A Securities InvestigationOct 29, 2026 · finance.yahoo.com
- What ClearPoint Neuro (CLPT) Said on Its Q3 Earnings CallOct 29, 2026 · marketbeat.com
- uniQure to Announce Third Quarter 2026 Financial ResultsOct 28, 2026 · finance.yahoo.com
About uniQure N.V.
uniQure N.V. (QURE) is a US-listed public company on Nasdaq.